HRI Inhibition by Hemin as a Novel Targeted Therapy for Glioblastoma via the Integrated Stress Response
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide
Article in Pharmaceuticals (March 2024)
Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via in vitro and molecular docking approaches
Article in Frontiers in Chemistry (February 2024)